Bio Green Med Net Income
| BGMS Stock | 1.01 0.03 3.06% |
As of the 16th of February 2026, Bio Green shows the Risk Adjusted Performance of (0.03), standard deviation of 7.7, and Mean Deviation of 5.35. Bio Green Med technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Bio Green Med variance and potential upside to decide if Bio Green Med is priced correctly, providing market reflects its regular price of 1.01 per share. Given that Bio Green is a hitting penny stock territory we recommend to closely look at its jensen alpha.
Bio Green Total Revenue |
|
| Last Reported | Projected for Next Year | ||
| Net Loss | -12.9 M | -13.5 M | |
| Net Loss | -12.9 M | -13.5 M | |
| Net Loss | (452.22) | (474.83) | |
| Net Income Per E B T | 1.08 | 0.98 |
Bio | Net Income | Build AI portfolio with Bio Stock |
The evolution of Net Income for Bio Green Med provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Bio Green compares to historical norms and industry peers.
Latest Bio Green's Net Income Growth Pattern
Below is the plot of the Net Income of Bio Green Med over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Bio Green Med financial statement analysis. It represents the amount of money remaining after all of Bio Green Med operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Bio Green's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bio Green's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (11.21 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Bio Net Income Regression Statistics
| Arithmetic Mean | (13,708,076) | |
| Coefficient Of Variation | (35.39) | |
| Mean Deviation | 3,914,526 | |
| Median | (13,186,000) | |
| Standard Deviation | 4,851,891 | |
| Sample Variance | 23.5T | |
| Range | 15.3M | |
| R-Value | (0.03) | |
| Mean Square Error | 25.1T | |
| R-Squared | 0.0008 | |
| Significance | 0.92 | |
| Slope | (26,722) | |
| Total Sum of Squares | 376.7T |
Bio Net Income History
Other Fundumenentals of Bio Green Med
Bio Green Net Income component correlations
Bio Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Bio Green is extremely important. It helps to project a fair market value of Bio Stock properly, considering its historical fundamentals such as Net Income. Since Bio Green's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Bio Green's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Bio Green's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Health Care Providers & Services market expansion? Will Bio introduce new products? Factors like these will boost the valuation of Bio Green. Projected growth potential of Bio fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Bio Green listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Bio Green Med's market price often diverges from its book value, the accounting figure shown on Bio's balance sheet. Smart investors calculate Bio Green's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Bio Green's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Bio Green's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bio Green should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Bio Green's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Bio Green 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bio Green's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bio Green.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Bio Green on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Bio Green Med or generate 0.0% return on investment in Bio Green over 90 days. Bio Green is related to or competes with Bone Biologics, Bullfrog, Applied DNA, CNS Pharmaceuticals, Venus Concept, Movano, and 60 Degrees. Bio Green is entity of United States. It is traded as Stock on NASDAQ exchange. More
Bio Green Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bio Green's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bio Green Med upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 42.74 | |||
| Value At Risk | (8.79) | |||
| Potential Upside | 12.8 |
Bio Green Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bio Green's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bio Green's standard deviation. In reality, there are many statistical measures that can use Bio Green historical prices to predict the future Bio Green's volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.52) | |||
| Total Risk Alpha | (0.93) | |||
| Treynor Ratio | (0.13) |
Bio Green February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.12) | |||
| Mean Deviation | 5.35 | |||
| Coefficient Of Variation | (2,210) | |||
| Standard Deviation | 7.7 | |||
| Variance | 59.34 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.52) | |||
| Total Risk Alpha | (0.93) | |||
| Treynor Ratio | (0.13) | |||
| Maximum Drawdown | 42.74 | |||
| Value At Risk | (8.79) | |||
| Potential Upside | 12.8 | |||
| Skewness | 1.64 | |||
| Kurtosis | 5.01 |
Bio Green Med Backtested Returns
Bio Green Med secures Sharpe Ratio (or Efficiency) of -0.0237, which signifies that the company had a -0.0237 % return per unit of risk over the last 3 months. Bio Green Med exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Bio Green's Risk Adjusted Performance of (0.03), standard deviation of 7.7, and Mean Deviation of 5.35 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 2.67, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Bio Green will likely underperform. At this point, Bio Green Med has a negative expected return of -0.18%. Please make sure to confirm Bio Green's potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Bio Green Med performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.21 |
Weak predictability
Bio Green Med has weak predictability. Overlapping area represents the amount of predictability between Bio Green time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bio Green Med price movement. The serial correlation of 0.21 indicates that over 21.0% of current Bio Green price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.21 | |
| Spearman Rank Test | -0.18 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Bio Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Bio Green Med reported net income of (11.21 Million). This is 103.29% lower than that of the Health Care Providers & Services sector and 116.01% lower than that of the Health Care industry. The net income for all United States stocks is 101.96% higher than that of the company.
Bio Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bio Green's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bio Green could also be used in its relative valuation, which is a method of valuing Bio Green by comparing valuation metrics of similar companies.Bio Green is currently under evaluation in net income category among its peers.
Bio Green Current Valuation Drivers
We derive many important indicators used in calculating different scores of Bio Green from analyzing Bio Green's financial statements. These drivers represent accounts that assess Bio Green's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Bio Green's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 14.9K | 18.8K | 21.3K | 134.3K | 120.9K | 126.9K | |
| Enterprise Value | (36.5M) | (18.2M) | (3.3M) | (3.0M) | (3.5M) | (3.6M) |
Bio Fundamentals
| Revenue | 43 K | ||||
| EBITDA | (12 M) | ||||
| Net Income | (11.21 M) | ||||
| Total Debt | 6.27 M | ||||
| Cash Flow From Operations | (7.99 M) | ||||
| Total Asset | 4.09 M | ||||
| Retained Earnings | (439.49 M) | ||||
| Working Capital | (2.59 M) | ||||
| Net Asset | 4.09 M |
About Bio Green Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bio Green Med's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio Green using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio Green Med based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Bio Stock Analysis
When running Bio Green's price analysis, check to measure Bio Green's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Green is operating at the current time. Most of Bio Green's value examination focuses on studying past and present price action to predict the probability of Bio Green's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Green's price. Additionally, you may evaluate how the addition of Bio Green to your portfolios can decrease your overall portfolio volatility.